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Background: Beta-defensin-2 (BD-2), an endogenous antimicrobial peptide, plays a key role in immune
response against microbial invasion. This study aimed to observe the effect of AlanyleGlutamine (Ala
eGln) on BD-2 protein expression in pulmonary tissues after intestinal ischemia reperfusion (IIR) in rats
and to investigate its correlations to pulmonary inﬂammatory and oxidative injury. Methods: Rats in IIR
and the two treatment groups were subjected to intestine ischemia for 60 min and those in the treat-
ment groups were administered orally with AlaeGln or alanine (Ala) respectively. Lung tissues were
harvested to detect the BD-2 protein expression. Concentrations of Tumor necrosis factor (TNF)-a and
malondialdehyde (MDA) as well as superoxide dismutase (SOD) activity in lung tissues were determined
simultaneously. Results: AlaeGln attenuated the up-regulation of BD-2 expression (p < 0.05) and TNF-a
(p < 0.05), MDA (p < 0.05) levels, as well as the reduction of SOD activity (p < 0.05) in lung tissues after
IIR. But Ala did not exert signiﬁcant effects. BD-2 protein in lung tissues was positively correlated to local
TNF-a level (p < 0.01) and MDA concentration (p < 0.01) with statistical signiﬁcance. Conclusion: Ala
eGln can relieve the IIR-induced up-regulation of BD-2 protein expression in the lung of rats, which
involves anti-inﬂammation and anti-oxidation mechanisms.
© 2014 Published by Elsevier Ltd on behalf of Surgical Associates Ltd.1. Introduction
IIR is a potentially life-threatening condition which can be
induced by various surgical procedures, such as liver and intestinetestinal Surgery, The Sixth
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f of Surgical Associates Ltd.transplantation, abdominal aortic surgery and postoperative ileus
being the most common complication of abdominal surgery [1].
The systemic inﬂammatory response syndrome (SIRS) resulting
from translocation of bacteria and endotoxin as a consequence of
IIR can cause injuries to remote organs including lung, heart, kidney
and liver, leading to multiple organ dysfunction syndrome (MODS)
at the end stage [2]. Among these distant organ injuries, acute lung
injury (ALI) or pneumonia develops frequently and is one of the
most common postoperative complications of abdominal surgery
[3]. IIR-induced ALI has been characterized by serious inﬂammation
Y. Li et al. / International Journal of Surgery 12 (2014) 1181e11861182with signiﬁcant recruitment of leucocytes and increased pulmo-
nary permeability that can lead to severe pulmonary edema [4,5].
It is generally accepted that defensins play a critical and indis-
pensable role in both innate and adaptive immune responses.
Multiply injured Patients showed elevated concentrations of
defensins in serum as compared to healthy donors [6]. Among
these defense peptides, BD-2 serves as an endogenous antimicro-
bial peptide that wasmainly produced by epithelial cells of skin and
respiratory tract [7]. It has been demonstrated that BD-2 is
expressed in rat lung [8] and plays an important role in maintaining
host defense on the face of microbial invasion via its chemo-
attractant effect on dendritic cells and T cells. Furthermore, in some
pulmonary inﬂammatory response BD-2 is up-regulated through
some proinﬂammatory factors such as TNF-a and shows a protec-
tive effect against inﬂammatory injury. It was found that IIR could
upregulate the expression of BD-2 and this phenomenon was
positively correlated to TNF-a level in the lung [5].
Glutamine (Gln) has been proved to be able to ameliorate IIR-
induced injury of remote organs including the mechanism of
limiting inﬂammatory reaction [9e11]. AlanyleGlutamine (AlaeGln),
anartiﬁcially syntheticdipeptidecontainingGln, is commonlyused in
clinical practice. However, the exact effect of immune-nutrients
administration on BD-2 level in lung after IIR and its relationship
with local inﬂammation and oxidative injury has not been elucidated
clearly. In the present study, the rat model of superior mesenteric
artery occlusion and reperfusion was employed to investigate the
alteration of BD-2 protein expression in the treatment of IIR-induced
lung injury via oral supplementation of AlaeGln.2. Materials and methods
2.1. Animals
This study was approved by Animal Care Committee of Ooo
University. All of the animal care and experimental protocols were
performed in accordance with National Institutes of Health
guidelines for the use of experimental animals. Forty healthy male
SpragueeDawley (SD) rats weighing between 200 and 250 g were
used in the current study. They were kept in an air-conditioned
room with a 12-h lightedark cycle. They were allowed standard
rat chow (free of Gln and Ala) and tap water ad libitum.2.2. Experimental design and establishment of IIRI model
Rats were randomly divided into sham operation (S), IIR,
AlaeGln and Ala groups, each of which contained 10 rats. Those in
AlaeGln group and Ala group were administered orally with
AlaeGln (Sino-Swed Pharmaceutical Co., Ltd, Wuxi, China) or Ala
(SigmaeAldrich, St Louis, MO, USA) at the dose of 0.6 g/kg d 3 days
before the ischemia procedure followed by the reperfusion period
of 72 h, except the day on which ischemia was conducted. Mean-
while rats in S group and IIR group have been administered with
physiological saline orally at the same points.
After fasted for 12 h before the operation, animals were anes-
thetized with pentobarbital (30 mg/kg, intraperitoneal injection).
Themodel of IIRwas treated byocclusion of the superiormesenteric
artery. Through a midline laparotomy, the superior mesenteric ar-
tery was located and isolated from the surrounding tissues, and a
vascular clipwas placed around the vessel near the aortic origin. The
abdominal incision was then temporarily closed, and the rat was
placedonaheatingpadduring the ischemicperiod.After60min, the
abdominal incisionwas opened, and the vascular clip was removed.
Reperfusion was noted by visual inspection of the intestine in each
animal, afterwhich the abdominal incisionwas permanently closed.A sham operation on control rats was carried out as above but
without placing the vascular clip on the superior mesenteric artery.
2.3. Samples of lung tissues
After the reperfusion procedure of 72 h (3 day), the rats were
reanesthetized with intraperitoneal pentobarbital (75 mg/kg) and
sacriﬁced by blood depletion. Then thoracic cavity of each animal
was opened, the right lower lung was harvested for immunohis-
tochemistry examination. The right lower lungs were utilized for
the detections of BD-2 protein expression and distribution by
immunohistochemistry, immunoﬂuorescence and western blotting
techniques, while the left upper and lower lungs were for the de-
terminations of TNF-a concentration, SOD activity and MDA level.
All the lung tissues were snap frozen with liquid nitrogen and
stored at 80 C until analysis.
2.4. Immunohistochemistry staining of BD-2
Pulmonary tissues stored in ultra low temperature freezer were
transferred to 20 C refrigerator for about 20 min and then
mounted on opti-mum cutting temperature compound (SAKURA,
USA) until slicing at 8 mm. The cryosections were ﬁxed in ice-cold
acetone for 15 min and incubated with 3% hydrogen peroxide at
room temperature for 10 min to block endogenous peroxidase ac-
tivity. After blockingwith phosphate buffered sodium containing 5%
fetal bovine serum, the slides were incubated overnight with a
1:1000 dilution of polyclonal primary antibody against BD-2
(Abbiotec, USA). The labeling was visualized by using horseradish
peroxidase (HRP)-conjugated secondaryantibody (Invitrogen,USA).
All incubation steps were performed in a humidiﬁed chamber. Then
the sectionswere stainedwith diaminobenzidine (DAB)þ Substrate
Buffer (Zhongshan Goldenbridge Biotechnology Co., Ltd, Beijing,
China) according to the manufacturer's instruction and counter-
stained with hematoxylin for 3 min and mounted with glass cov-
erslips. Examination was performed under light microscopy.
2.5. Immunoﬂuorescence detection of BD-2
The preparation and ﬁxation of cryosections was conducted as
described previously. The sections were incubated with a 1:800
dilution of polyclonal primary antibody against BD-2 overnight at
4 C and then with ﬂuorescein isothiocyannate (FITC)- secondary
antibody against rabbit (Invitrogen, USA) at the same dilution for
1 h at 37 C. Mounting medium for ﬂuorescence with DAPI (Vector
laboratories Inc. USA) was added for staining of nucleuses just
before the examination the ﬂuorescent signals of BD-2 protein
under ﬂuorescence microscope.
2.6. Assessment of TNF-a level in lungs
TNF-a concentration in the lung were assessed by using
commercially available ELISA kits according to the manual book
provided by the manufacturer (Dakewe biotech Co., Ltd, China).
Pulmonary tissues were homogenised on ice with physiological
saline (1:9 w/v) and then centrifuged for 10 min at 3000 rpm/min.
Supernatants were collected for the further assessment. Brieﬂy,
0.1 ml supernatants were incubated with the 50 ml biotinylated
antibody for 90 min at 37 C and then washed four times. 0.1 ml
streptavidin- HRP was added for per sample and incubated for
30 min at 37 C. After washed for anther four times the substrate
solution was added. The reaction system was kept from light for
20 min at 37 C. The optical density at 450 nmwas detected with a
microplate reader.
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Homogenization of lung tissues was prepared as above.
Commercially available kits for detections of SOD activity and MDA
concentration were used based on the protocol provided by the
manufacturer (Nanjing Jiancheng Corp., China).2.8. Western blotting analysis for detection of BD-2 protein
Lung tissues were homogenised with ice-cold RIPA Buffer
(Thermo, USA) containing 1% Protease Inhibitor (cocktail kit,
Thermo, USA). The homogenates were vortexed for 5 s and incu-
bated on ice for 1 min. After vortexed for another 5 s, the homog-
enates were centrifuged at 14,000 rpm, 4 C for 5 min. The
supernatants were collected as tissue extracts and kept at 80 C.
Protein concentration was determined by BCA protein assay kit
(Thermo Fisher Scientiﬁc Inc., USA). Aliquots of 30 mg protein of
each rat were electrophoresed on a 12% SDS-polyacrylamide gel for
1.5 h at 120 V and transferred onto a nitrocellulose membrane. The
membrane was incubated with blocking solution (Tris buffered
saline with Tween 20 containing 5% nonfat milk) for 1 h at room
temperature and then probed with primary antibody against BD-2
(Abbiotec, USA) overnight at 4 C. After washed with TBST (Tris
buffered saline with Tween 20, 1000:1 of v/v) for 3 times, the
membrane was incubated with a horseradish peroxidase-labeled
secondary antibody for 1 h at room temperature. Protein bands
were visualized with chemiluminescence detection. Optical densityFig. 1. Expression of BD-2 protein in lungs assessed by immunohistochemistry staining un
group showed a very low level of BD-2 expression (as shown by arrows). (A); Apparent posit
in Ala and IIR groups (as shown by arrows). (C and D); In AlaeGln group, the positive staining
references to color in this ﬁgure legend, the reader is referred to the web version of this arof protein bands corresponding to BD-2 were quantiﬁed by Image-
Pro Plus software.2.9. Statistical analysis
Statistical analysis was performed using SPSS 16.0 software
(IBM, USA). All data were expressed as Means ± SD. One-way
analysis of variance (ANOVA) was used for multiple comparison.
LSD-t test was used for intra-group comparison or Tamhane's T2
test was used if equal variances were not assumed. The relation-
ships of BD-2 protein expression level with TNF-a and MDA con-
centration in pulmonary tissues were evaluated by Pearson
correlation test. Differences at p < 0.05 were considered signiﬁcant.3. Results
3.1. Immunohistochemistry staining of BD-2
In S group, BD-2 had a constitutive expression in which both
intra-cellular and ecto-cellular immunoreactivity were observed
somewhat. In IIR group, the expression of BD-2 in lung was
increased signiﬁcantly and the distribution was mainly in bron-
chiole epitheliums and pulmonary mesenchymal compartments.
Expression level of BD-2 was decreased signiﬁcantly in AlaeGln
group compared to IIR group. However, there is no marked differ-
ence between Ala and IIR group (Fig 1).der the light microscopy (400). The brown color indicated BD-2 positive staining. S
ive staining was observed mainly in bronchiole epithelium and pulmonary interstitium
of BD-2 was much weaker than that in IIR and Ala groups (B). (For interpretation of the
ticle.)
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Immunoﬂuorescence revealed the laminated expression of BD-2
protein along bronchiole wall more distinctly than the immuno-
histochemistry technique. S group showed a monoptychial
expression of BD-2 in bronchiole wall; Signiﬁcantly enhanced sig-
nals were observed in IIR and Ala groups, which were visualized as
multilaminar in bronchiole wall; In AlaeGln group, the distribution
of BD-2 proteinwas similar to S group and the ﬂuorescent intensity
was much weaker than that in IIR and Ala groups (Fig 2).3.3. BD-2 protein expression detected by western blotting analysis
Western blotting demonstrated that weak positive signal was
found in the S group and a signiﬁcant up-regulation in band in-
tensity corresponding to BD-2 protein was observed in IIR and Ala
group. The gray scale of band corresponding BD-2 protein was
decreased signiﬁcantly in AlaeGln group as compared with IIR and
Ala groups. The alterations of BD-2 protein expression in lung
detected by western blotting were in line with the results of
immunohistochemistry and immunoﬂuorescence studies (Fig 3).3.4. Changes of TNF-a level in lungs
IIR led to signiﬁcant increases in concentrations of TNF-a in lung
tissues as comparedwith S group (p < 0.01). TNF-a concentration in
AlaeGln group was lower signiﬁcantly than that in IIR groupFig. 2. Expression signals of BD-2 protein in lungs assessed by immunoﬂuorescence detec
distinctly. S group showed a monoptychial expression of BD-2 in bronchiole wall (A); Stronge
bronchiole wall (C and D); In AlaeGln group, the distribution of BD-2 protein were similar to
(B).(p < 0.05). However, there was no signiﬁcant difference between
Ala and IIR group (p > 0.05) (Fig 4).
3.5. Changes of SOD activity and MDA concentration in lungs
In IIR groups, the SOD activity in pulmonary tissues was
decreased (p < 0.01) and MDA concentration was increased
(p < 0.05) signiﬁcantly compared to S group. In AlaeGln group,
changes of SOD activity and MDA concentration were attenuated
markedly (p< 0.05). However, therewas no signiﬁcant difference in
these two parameters between Ala and IIR group (p > 0.05) (Fig 5).
3.6. Correlation analysis
BD-2 protein expression level detected by western blotting in
lung tissues was signiﬁcantly positively correlated to local TNF-a
level (r ¼ 0.934, p < 0.01) and MDA concentration (r ¼ 0.891,
p < 0.01).
4. Discussions
AlaeGln is used as the substitute of Gln in clinical practice
because of its advantages over the latter, which include more sta-
bleness in aqueous solution and the property of withstanding high
temperature sterilization. Thus oral supplementation of AlaeGln
was used to assess the effects of immune-nutrient on IIR-related
lung injury and Ala was used in current research to exclude the
effects of common amino acid.tion (400). The laminated expressions of BD-2 along bronchiole wall were displayed
r signals were observed in Ala and IIR groups, which were visualized as multilaminar in
S group and the ﬂuorescent intensity was much weaker than that in IIR and Ala groups
Fig. 3. Western blotting analysis of BD-2 expression in the lung tissues. A: The classical
bands of BD-2 and b-actin in the four groups. The prominent bands of BD-2 protein
were indicated at approximately 7 kDa. The intensity of BD-2 protein in Ala and IIR
groups was prominent over that in S and AlaeGln groups. B: The gray scales of bands
corresponding to BD-2 protein were normalized as the ratios to the same parameters
of b-actin. The expression of BD-2 protein in Ala and IIR groups was increased
signiﬁcantly compared to S group (p < 0.01), while the down-regulation of the
micromolecular protein was marked in AlaeGln group as compared with IIR group
(p < 0.05). **p < 0.01 vs S group; #p < 0.05 vs IIR group. n ¼ 10 rats per group.
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acute lung injury and various mechanisms probably employed have
been explored [9,10]. However, to our knowledge, the present study is
the ﬁrst to observe the changes of lung BD-2 protein expression in
the treatment of IIR related lung injury in rats by using immunohis-
tochemistry, immunoﬂuorescence and western blotting techniques.Fig. 4. Changes of TNF-a concentration in rat lung tissues. Data are mean ± S.D.
**p < 0.01 vs S group; #p < 0.05 vs IIR group. n ¼ 10 rats per group.BD-2 exerts a broad spectrum antimicrobial activity by destroying
the cytoplasmicmembrane ofmicroorganisms and canbe inducedby
various kinds of inﬂammatory stimuli. Abundant researches have
demonstrated that BD-2 is a favorable factor involved in adaptive
defenseagainst the lung injuryresulting fromsomediseases [12,13]. It
was well established that BD-2 has chemoattractant effect on
immature dendritic cell and CD4þ Tcell via chemokine receptor CCR6
[7]. So promoting recruitment of dendritic cell and Tcell to the site of
inﬂammatory response is one of themost important mechanisms by
which BD-2 inhibits inﬂammatory injury of local organs.
The present study revealed that the up-regulated level of BD-2
protein in the lung after IIR was decreased by oral administration
of AlaeGln in rats. This is a novel ﬁnding. There are two explana-
tions mainly for this phenomenon. Firstly, BD-2 in pulmonary tis-
sue is correlated tightly to local microbial invasion and
proinﬂammatory mediators, it can be induced by a variety of
stimuli including TNF, IL-1 and lipopolysaccharide (LPS) [14].
In vitro, bacterial infections in the lung can enhance BD-2 expres-
sion [15]. Nuclear factor-kB (NF-kB), an transcription facilitative
factor of proinﬂammatory cytokines, can up-regulate the expres-
sion of BD-2 in pulmonary epithelial cells through the actions of IL-
1 and TNF-a [16]. Secondly, the disruption of intestinal barrier afterFig. 5. Changes of SOD activity (A) and MDA concentration (B) in rat lung tissues. Data
are mean ± S.D. *p < 0.05, **p < 0.01 vs S group; #p < 0.05 vs IIR group. n ¼ 10 rats per
group.
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central role in the development of systemic inﬂammation that can
result in damage to remote organs. Under traumatic and stress
conditions, Gln is the preferred fuel for the enterocyte and is
beneﬁcial for maintaining intestinal mucosal barrier function. After
Gln administration, prevention against increased intestinal
permeability [17] and inhibition of bacteria and endotoxin trans-
locations to lung from gut after IIR were observed [18]. In the
current study, by utilizing rat model we revealed that AlaeGln was
capable of attenuating the up-regulation of TNF-a concentration in
lung tissues caused by IIR, which was responsible for the reduction
of BD-2 protein expression by AlaeGln administration.
In addition, the great generation of free radicals released from
polymorphonuclear leukocytes (PMNL) mobilized at the initial
stage of reperfusion process [19] could lead to oxidative damage
directly in the lung. Gln has protective effects against redox
disturbance and oxidative stress resulting from free radicals by
generating glutathione (GSH), a major antioxidant and a vital
component of a host's defense. Gln can exert a potent inhibitive
effect in nitric oxide (NO) biosynthesis, which is thought to be
involved in ischemia reperfusion injury [20]. In this study, admin-
istration of AlaeGln attenuated the IIR-induced down-regulation of
SOD activity in rats that is a highly speciﬁc scavenger of superoxide.
Meanwhile, we observed that the lung MDA level, which was
considered as an important marker of lipoperoxidation associated
to oxidative stress [21], was increased after IIR and could be down-
regulated by AlaeGln oral administration. These effects were due to
the function of AlaeGln in maintaining redox homeostasis under
the condition of serious trauma. Moreover, it was demonstrated in
present study that the changed trend of BD-2 protein expression in
the lung after application of AlaeGln was paralleled with the al-
terations of local concentration of TNF-a and MDA. The observation
suggested that AlaeGln could modify the level of BD-2 in IIR-
induced lung injury in rats via limiting pulmonary inﬂammatory
and oxidative injury. Similarly to the previous research focusing on
the relationship between BD-2 protein and airway inﬂammation
[13], it also can be concluded from the results of the current study
that the expression level of BD-2 protein is able to serve as a useful
marker of pulmonary injury induced by IIR. However, in order to
reveal the exact functions of BD-2 protein in the development and
treatment of IIR-induced lung injury further studies employing
speciﬁc BD-2 inhibitor or gene knock-out models are required.
In conclusion, oral administration of AlaeGln can exert a pro-
tection against IIR-induced lung injury in rats and relieve the IIR-
induced up-regulation of BD-2 protein expression in the lung
through anti-inﬂammation and anti-oxidation mechanisms.
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